Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Adaptive intensity-modulated proton therapy with 4D robust planning: A dose mimicking approach
Stockholm University, Faculty of Science, Department of Physics. RaySearch Laboratories AB (Publ), Stockholm, Sweden.ORCID iD: 0000-0002-8441-3595
OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
RaySearch Laboratories AB (Publ), Stockholm, Sweden.
RaySearch Laboratories AB (Publ), Stockholm, Sweden.
Show others and affiliations
(English)Manuscript (preprint) (Other academic)
Abstract [en]

Objective: A 4D robust optimisation (4DRO) is usually employed when the tumour respiratory motion needs to be addressed. However, it is computationally demanding, and an automated method is preferable for adaptive planning to avoid manual trial-and-error. This study proposes a 4DRO technique based on dose mimicking for adaptive planning.

Approach: Initial plans for 4D robust IMPT were created on an average CT (avgCT) for four patients with clinical target volume (CTV) in the lung, oesophagus, or pancreas, respectively. These plans were robustly optimized using three phases of 4DCT and accounting for setup and density uncertainties. Weekly 4DCTs were used for adaptive replanning, using a constant relative biological effectiveness (cRBE) of 1.1. Two methods were used for this purpose: (1) template-based adaptive (TA) planning and (2) dose-mimicking-based adaptive (MA) planning. The plans were evaluated using variable RBE (vRBE) weighted doses and biologically consistent dose accumulation (BCDA).

Main results: TA and MA plans had comparable CTV coverage except for one case where MA plan had a higher D98 and D2 but with an increased D2 in an OAR. CTV D98 deviations in non-adaptive plans from the initial plans were up to -7.2% in individual plans and -1.8% when using BCDA. For the OARs, MA plans showed a reduced mean dose and D2 compared to the TA plan, with few exceptions. The vRBE-weighted dose had a mean dose and D2 difference of up to 0.3 Gy and 0.5 Gy, respectively, in the OARs with respect to cRBE-weighted dose.

Significance: MA plans indicate better performance in target coverage and OAR dose sparing compared to the TA plans. Moreover, MA method is capable of handling both forms of anatomical variation, namely, changes in density and relative shifts in the position of the OARs.

National Category
Cancer and Oncology Other Physics Topics
Research subject
Medical Radiation Physics
Identifiers
URN: urn:nbn:se:su:diva-229127OAI: oai:DiVA.org:su-229127DiVA, id: diva2:1857419
Projects
European Union’s Horizon 2020 Marie Skłodowska-Curie Actions under Grant Agreement No. 955956Available from: 2024-05-13 Created: 2024-05-13 Last updated: 2024-05-13
In thesis
1. Robust optimization considering uncertainties in adaptive proton therapy.
Open this publication in new window or tab >>Robust optimization considering uncertainties in adaptive proton therapy.
2024 (English)Licentiate thesis, comprehensive summary (Other academic)
Abstract [en]

Proton therapy, a promising alternative to conventional photon therapy, has gained widespread acceptance in clinical practice. This is attributed to its superior depth-dose curve that has a negligible dose beyond the maximum range of the proton. A proton treatment planning requires a multitude of parameters and are either manually selected or optimized using mathematical formulation. However, a proton treatment plan is also subject to various systematic and random uncertainties that must be taken into account during optimization. Robust optimization is a commonly used method for integrating the setup and range uncertainties in proton therapy.

In addition to the uncertainties accounted for during the treatment planning phase, others can arise during the course of treatment and are often hard to predict. Changes in the patient's anatomy represent uncertainties that can significantly affect planned dose delivery. Therefore, adaptive planning is typically performed intermittently or regularly, depending on the changes in anatomy. Paper II included in this thesis proposed a method of adaptive planning that takes into account the impact of the patient's respiratory motion at the treatment site, such as the lungs and abdomen for 4D robust optimization. This method uses dose mimicking to reproduce the results as initially planned.  

This additional stage of adaptive planning can introduce new complexities and uncertainties into the treatment process. One such uncertainty arise from daily cone beam computed tomography (CBCT) images which are required for treatment plan adaptation. Several strategies have been proposed in the past to improve the quality of these images, but each strategy has its advantages and disadvantages, depending on the site of treatment. In Paper I, a method was proposed that combined the advantages of other frequently used methods to create an improved method for generating daily images with CT-like image quality. This can contribute towards the goal of online adaptive in the near future with reduced uncertainties.

This thesis will provide a brief introduction and an in-depth chapter to elucidate the background, better understand the physics of proton therapy, the process of treatment planning, and the need for adaptive planning.

Place, publisher, year, edition, pages
Stockholm: Department of Physics, Stockholm University, 2024
Keywords
Proton therapy, Robust optimization, Adaptive radiation therapy
National Category
Physical Sciences
Research subject
Medical Radiation Physics
Identifiers
urn:nbn:se:su:diva-229129 (URN)
Presentation
2024-06-03, CCK Lecture Hall, Cancer Center Karolinska (CCK), Karolinska Universitetssjukhuset, 171 76 Solna, Solna, 09:00 (English)
Opponent
Supervisors
Projects
European Union’s Horizon 2020 Marie Skłodowska-Curie Actions under Grant Agreement No. 955956
Funder
EU, Horizon 2020, 955956
Available from: 2024-05-13 Created: 2024-05-13 Last updated: 2024-05-13Bibliographically approved

Open Access in DiVA

No full text in DiVA

Search in DiVA

By author/editor
Kaushik, Suryakant
By organisation
Department of Physics
Cancer and OncologyOther Physics Topics

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 269 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf